Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,101 to 2,120 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. | Blood Cancer J | 2018 | 30420667 | PubTator, text mining | PubMed |
| Chronic myeloid leukemia extramedullary blast crisis presenting as central nervous system leukemia: A case report. | Medicine (Baltimore) | 2018 | 30407337 | PubTator, text mining | PubMed |
| Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives. | Int J Mol Sci | 2018 | 30404199 | PubTator, text mining | PubMed |
| Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis. | Sci Rep | 2018 | 30401833 | PubTator, text mining | PubMed |
| Norepinephrine triggers an immediate-early regulatory network response in primary human white adipocytes. | BMC Genomics | 2018 | 30390616 | PubTator, text mining | PubMed |
| Primary Philadelphia chromosome positive acute myeloid leukemia: A case report. | Medicine (Baltimore) | 2018 | 30383645 | PubTator, text mining | PubMed |
| Acute myeloid leukemia with new complex t(8;21;22) induced hemophagocytic lymphohistiocytosis: A case report. | Medicine (Baltimore) | 2018 | 30383631 | PubTator, text mining | PubMed |
| KMT2B Is Selectively Required for Neuronal Transdifferentiation, and Its Loss Exposes Dystonia Candidate Genes. | Cell Rep | 2018 | 30355503 | PubTator, text mining | PubMed |
Low-dose hypomethylating agent decitabine in combination with aclacinomycin and cytarabine achieves a better outcome than standard FLAG chemotherapy in refractory/relapsed acute myeloid leukemia patients with poor-risk cytogenetics and mutations. | Onco Targets Ther | 2018 | 30349319 | PubTator, text mining | PubMed |
| Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer. | Front Pharmacol | 2018 | 30333750 | PubTator, text mining | PubMed |
| Functional genomic landscape of acute myeloid leukaemia. | Nature | 2018 | 30333627 | PubTator, text mining | PubMed |
| PML-RARα interferes with erythropoiesis by repressing LMO2 in acute promyelocytic leukaemia. | J Cell Mol Med | 2018 | 30320491 | PubTator, text mining | PubMed |
| Integrated analysis of long noncoding RNA interactions reveals the potential role in progression of human papillary thyroid cancer. | Cancer Med | 2018 | 30318850 | PubTator, text mining | PubMed |
| Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report. | Medicine (Baltimore) | 2018 | 30313079 | PubTator, text mining | PubMed |
| Pseudo-Chediak-Higashi granules in myeloid cells in therapy-related AML with RUNX1-RUNX1T1. | Blood Res | 2018 | 30310783 | PubTator, text mining | PubMed |
| Epigenetic Modifiers in Myeloid Malignancies: The Role of Histone Deacetylase Inhibitors. | Int J Mol Sci | 2018 | 30304859 | PubTator, text mining | PubMed |
| The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation. | Cancer Cell | 2018 | 30300583 | PubTator, text mining | PubMed |
| Genetic Models of Leukemia in Zebrafish. | Front Cell Dev Biol | 2018 | 30294597 | PubTator, text mining | PubMed |
| Identification of Key Genes and Pathways Associated with RUNX1 Mutations in Acute Myeloid Leukemia Using Bioinformatics Analysis. | Med Sci Monit | 2018 | 30289875 | PubTator, text mining | PubMed |
| Eprobe mediated RT-qPCR for the detection of leukemia-associated fusion genes. | PLoS One | 2018 | 30281597 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=106